Christopher Robinson/LinkedIn
Jun 13, 2026, 14:29
Christopher Robinson: SNRI vs SSRI and the Risk of Hypertensive Disorders of Pregnancy
Christopher Robinson, Associate Professor Maternal Fetal Medicine at University of South Carolina, shared a post on LinkedIn:
“Serotonin-norepinephrine reuptake inhibitors vs selective serotonin reuptake inhibitors and the risk of hypertensive disorders of pregnancy”
Title: Serotonin-norepinephrine reuptake inhibitors vs selective serotonin reuptake inhibitors and the risk of hypertensive disorders of pregnancy
Authors: Anick Bérard, Yves Mufike Lumu, Gabra Nohmie, Narimene Ait Belkacem
Read the full article.
Stay updated on all scientific advances in the field of fertility with Fertility News.
-
Jun 13, 2026, 15:58Sergei Gorlovetsky: Excited to Be Attending ESHRE 2026 in London as Part of Fertiligent AI
-
Jun 13, 2026, 15:50The Real Reason IVF Success Falls With Age – Fertility Plus
-
Jun 13, 2026, 15:15Marco Zaccaria: How to Use Power Doppler Ultrasound in Transvaginal Assessment of Uterine Fibroids
-
Jun 13, 2026, 14:42Nilofer Husain: ABHI Report Calls for Sustained Action on Women’s Health Inequalities
-
Jun 12, 2026, 14:37ACOG Releases 2026 Maternal Immunization Schedule for Pregnant and Postpartum Patients – SMFM
-
Jun 12, 2026, 14:15Camille Clare: Representing Obstetrics and Gynecology at the AMA House of Delegates!
-
Jun 12, 2026, 14:13Amos Grünebaum: Balancing Autonomy and Safety in Freebirth Counseling!
-
Jun 12, 2026, 14:08Marco Zaccaria: How Do Elastic Centripetal Forces Lead to Dynamic Changes in the Myometrial Free Margin as Regards Submucous Myomas?
-
Jun 12, 2026, 14:01Heghine Khachatryan: What Should We Test from a Hematology Perspective?